Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter D Arkwright

Showing results (131-140 of 170) with videos related to

Pageof 17
Sort By:
Blood|January 30, 2009
FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of functionAude Magerus-Chatinet, Marie-Claude Stolzenberg, Maria S Loffredo, et al.
Journal of the American Academy of Dermatology|June 24, 2020
Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trialAmy S Paller, Elaine C Siegfried, Diamant Thaçi, et al.
Blood|October 26, 2013
IL-21 signalling via STAT3 primes human naive B cells to respond to IL-2 to enhance their differentiation into plasmablastsLucinda J Berglund, Danielle T Avery, Cindy S Ma, et al.
Blood|March 10, 2012
Functional STAT3 deficiency compromises the generation of human T follicular helper cellsCindy S Ma, Danielle T Avery, Anna Chan, et al.
The Journal of Allergy and Clinical Immunology|July 9, 2013
Signal transducer and activator of transcription 3 (STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8(+) T-cell memory formation and functionMegan L Ives, Cindy S Ma, Umaimainthan Palendira, et al.
The Journal of Experimental Medicine|February 4, 2010
Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type IAnne Puel, Rainer Döffinger, Angels Natividad, et al.
Journal of Autoimmunity|June 30, 2015
Marked variability in clinical presentation and outcome of patients with C1q immunodeficiencyRosanne A van Schaarenburg, Lone Schejbel, Lennart Truedsson, et al.
The Journal of Experimental Medicine|May 6, 2015
STAT3 is a critical cell-intrinsic regulator of human unconventional T cell numbers and functionRobert P Wilson, Megan L Ives, Geetha Rao, et al.
Lancet (London, England)|September 18, 2022
Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trialAmy S Paller, Eric L Simpson, Elaine C Siegfried, et al.
Journal of Clinical Immunology|October 29, 2024
Hematopoietic Stem Cell Transplantation for C1q Deficiency: A Study on Behalf of the EBMT Inborn Errors Working PartyHelena Buso, Etai Adam, Peter D Arkwright, et al.
Pageof 17

Showing results (131-140 of 170) with videos related to

Sort By:
Pageof 17
Blood|January 30, 2009
FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of functionAude Magerus-Chatinet, Marie-Claude Stolzenberg, Maria S Loffredo, et al.
Journal of the American Academy of Dermatology|June 24, 2020
Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trialAmy S Paller, Elaine C Siegfried, Diamant Thaçi, et al.
Blood|October 26, 2013
IL-21 signalling via STAT3 primes human naive B cells to respond to IL-2 to enhance their differentiation into plasmablastsLucinda J Berglund, Danielle T Avery, Cindy S Ma, et al.
Blood|March 10, 2012
Functional STAT3 deficiency compromises the generation of human T follicular helper cellsCindy S Ma, Danielle T Avery, Anna Chan, et al.
The Journal of Allergy and Clinical Immunology|July 9, 2013
Signal transducer and activator of transcription 3 (STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8(+) T-cell memory formation and functionMegan L Ives, Cindy S Ma, Umaimainthan Palendira, et al.
The Journal of Experimental Medicine|February 4, 2010
Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type IAnne Puel, Rainer Döffinger, Angels Natividad, et al.
Journal of Autoimmunity|June 30, 2015
Marked variability in clinical presentation and outcome of patients with C1q immunodeficiencyRosanne A van Schaarenburg, Lone Schejbel, Lennart Truedsson, et al.
The Journal of Experimental Medicine|May 6, 2015
STAT3 is a critical cell-intrinsic regulator of human unconventional T cell numbers and functionRobert P Wilson, Megan L Ives, Geetha Rao, et al.
Lancet (London, England)|September 18, 2022
Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trialAmy S Paller, Eric L Simpson, Elaine C Siegfried, et al.
Journal of Clinical Immunology|October 29, 2024
Hematopoietic Stem Cell Transplantation for C1q Deficiency: A Study on Behalf of the EBMT Inborn Errors Working PartyHelena Buso, Etai Adam, Peter D Arkwright, et al.
Pageof 17